Nebenwirkungen · Ulunar Breezhaler
Ulunar Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules · Abschnitt 4.8 · PDF-Seite 7
HOS-221019 · Präparat HOS-216760
Adverse reactions detected during clinical trials and from post-marketing sources are listed by MedDRA system organ class (Table 1). Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000, <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-25T17:00:00Z · SHA-256 feb22e21a651dff4c769ae573326fcbecc7ac63f564a25098198df9e6a3e4409 · Passage 7534ae4a8fc01bfdee2171251aa905dba2c73b4b5a1b77de25378b7ad81d7fb0 · Zeichen 915–1566 im Abschnitt